Abstract
Sacubitril is an ethyl ester prodrug of LBQ657, the active neprilysin (NEP) inhibitor, and a component of LCZ696 (sacubitril/valsartan). We report herein the three-dimensional structure of LBQ657 in complex with human NEP at 2 Å resolution. The crystal structure unravels the binding mode of the compound occupying the S1, S1' and S2' sub-pockets of the active site, consistent with a competitive inhibition mode. An induced fit conformational change upon binding of the P1'-biphenyl moiety of the inhibitor suggests an explanation for its selectivity against structurally homologous zinc metallopeptidases.
MeSH terms
-
Aminobutyrates / chemistry*
-
Aminobutyrates / metabolism
-
Biphenyl Compounds / chemistry*
-
Biphenyl Compounds / metabolism
-
Catalytic Domain
-
Crystallography, X-Ray
-
Drug Combinations
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / metabolism
-
Humans
-
Hydrogen Bonding
-
Models, Molecular
-
Neprilysin / antagonists & inhibitors
-
Neprilysin / chemistry*
-
Neprilysin / metabolism*
-
Protein Domains
-
Tetrazoles / metabolism
-
Valsartan
Substances
-
Aminobutyrates
-
Biphenyl Compounds
-
Drug Combinations
-
Enzyme Inhibitors
-
LBQ657
-
Tetrazoles
-
Valsartan
-
Neprilysin
-
sacubitril and valsartan sodium hydrate drug combination